Clinical Trials Logo

Clinical Trial Summary

The muscarinic antagonist tolterodine is widely used treat urinary urge incontinence. Though acteylcholine is the primary excitatory neurotransmitter in the gastrointestinal tract, the phase III trials suggest that tolterodine infrequently causes constipation. Therefore, the objectives of this study are to assess if tolterodine affects the speed at which food travels through the stomach, intestines and colon (i.e., gastrointestinal and colonic transit) in healthy subjects.


Clinical Trial Description

The specific aims of this study are to test the hypotheses that the non-specific muscarinic antagonist tolterodine will not:- i) delay colonic transit and the proximal colonic emptying rate; ii) delay gastric emptying; nor iii) delay small intestinal transit compared to placebo in healthy subjects. ;


Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00332137
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase Phase 2
Start date September 2005
Completion date August 2007

See also
  Status Clinical Trial Phase
Completed NCT03601715 - Analysis of Human Tissue Temperature After Application of Therapeutic Modalities. N/A
Completed NCT02145273 - Healthy Moms-Healthy Kids: Reducing Maternal Depression for Better Outcomes in Head Start Children N/A
Recruiting NCT01985152 - A Phase Ⅰa Study of Azilsartan Trimethylethanolamine in Healthy Volunteers Phase 1
Active, not recruiting NCT00970398 - Effect of an Infant Formula on Infant Growth, Health and Immune Functions N/A
Recruiting NCT06060379 - Giochiamo 626 - Gaming for Health and Safety in Workplaces N/A
Completed NCT04998266 - Evaluation of Physical Capacities Within the Company and Effect of a Personalized Versus Traditional Training Program on the Quality of Life of Sedentary Employees N/A
Completed NCT01214278 - Bioavailability of Different n-3 Fatty Acid Formulations Phase 4
Recruiting NCT06157346 - Characteristics of Intestinal Bacteria and Their Effects on Growth and Immune Function in Children at High Altitude
Completed NCT01057368 - The Effects of Well-being Interventions on Affect, Attention, Sleep, Social Stress and Pain Regulation N/A
Completed NCT01216605 - Oxytocin and Emotion Recognition Phase 4
Completed NCT02287441 - Feasibility Study to Increase Vegetable Consumption N/A
Recruiting NCT02132741 - Optical Coherence Tomography And NEphropathy: The OCTANE Study
Completed NCT01762553 - TEA for Families and Children: A Randomized Intervention Trial N/A
Completed NCT01123772 - Phase I Dose-Escalation Study to Evaluate Tolerability, Safety & PK of INO-8875 in Healthy Older-Adult Volunteers Phase 1
Completed NCT03527654 - SER Hispano Longitudinal Study
Completed NCT03414346 - Analysis of the Effects on Human Tissues After Application of Therapeutic Modalities. N/A
Completed NCT02116283 - Mobile Sensing of Smoking Behavior N/A
Completed NCT05104385 - Hacettepe University COVID-19 Vaccinated's Health Cohort- Students of Health Sciences
Completed NCT00962195 - The Effect of Purple Sweet Potato (PSP)-Juice on Liver Enzymes and Blood Pressure N/A
Completed NCT03788109 - Relationship Between Gastric Accommodation, TLESRs and Reflux in HV and in GERD With or Without Overlapping Dyspepsia N/A